Compare INMB & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | SNAL |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.3M | 29.8M |
| IPO Year | 2018 | 2022 |
| Metric | INMB | SNAL |
|---|---|---|
| Price | $1.33 | $0.65 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.30 | N/A |
| AVG Volume (30 Days) | ★ 408.0K | 13.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | N/A | ★ N/A |
| Revenue | $14,000.00 | ★ $84,467,047.00 |
| Revenue This Year | $264.29 | N/A |
| Revenue Next Year | N/A | $50.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 38.69 |
| 52 Week Low | $1.21 | $0.58 |
| 52 Week High | $11.64 | $2.15 |
| Indicator | INMB | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 37.84 | 57.84 |
| Support Level | $1.21 | $0.66 |
| Resistance Level | $1.71 | $0.98 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 19.24 | 90.85 |
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.